Calliditas Therapeutics AB
(NAS:CALT)
$
40.0001
-0.1599 (-0.4%)
Market Cap: 1.08 Bil
Enterprise Value: 1.10 Bil
PE Ratio: 0
PB Ratio: 104.30
GF Score: 35/100 Calliditas Therapeutics AB Nefigard Topline Data Presentation Transcript
Mar 13, 2023 / 12:00PM GMT
Release Date Price:
$22.42
(+33.23%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot